TrialJournal of hematology & oncology2016

Co-infusion of haplo-identical CD19-chimeric antigen receptor T cells and stem cells achieved full donor engraftment in refractory acute lymphoblastic leukemia.

Bo Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.